| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 685 |
| 1 | TESTOSTERONE | 119 |
| 2 | PREDNISONE | 68 |
| 3 | ADALIMUMAB | 67 |
| 4 | ACETAZOLAMIDE | 66 |
| 5 | ACETAZOLAMIDE SODIUM | 66 |
| 6 | MINOCYCLINE | 61 |
| 7 | DOXYCYCLINE | 60 |
| 8 | DOXYCYCLINE HYCLATE | 60 |
| 9 | MONTELUKAST SODIUM | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARSENIC TRIOXIDE | 46 | 0.0199 |
| 1 | ACETAZOLAMIDE SODIUM | 66 | 0.0107 |
| 2 | TRETINOIN | 43 | 0.0052 |
| 3 | MINOCYCLINE | 61 | 0.0052 |
| 4 | TESTOSTERONE CYPIONATE | 47 | 0.0052 |
| 5 | TESTOSTERONE | 119 | 0.0050 |
| 6 | CICLESONIDE | 48 | 0.0035 |
| 7 | LEVONORGESTREL | 685 | 0.0034 |
| 8 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 15 | 0.0016 |
| 9 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 49 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 722 |
| 1 | Progestin-containing Intrauterine System [EPC] | 686 |
| 2 | Corticosteroid [EPC] | 185 |
| 3 | Androgen [EPC] | 121 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 99 |
| 5 | Atypical Antipsychotic [EPC] | 91 |
| 6 | Retinoid [EPC] | 75 |
| 7 | Carbonic Anhydrase Inhibitor [EPC] | 66 |
| 8 | Tetracycline-class Drug [EPC] | 61 |
| 9 | Recombinant Human Growth Hormone [EPC] | 51 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 8 | 0.0116 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 2 | 0.0070 |
| 2 | Androgen [EPC] | 121 | 0.0044 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 66 | 0.0033 |
| 4 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 5 | Progestin [EPC] | 722 | 0.0025 |
| 6 | Recombinant Human Growth Hormone [EPC] | 51 | 0.0023 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 16 | 0.0023 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |
| 9 | Provitamin D2 Compound [EPC] | 49 | 0.0016 |